 | • レポートコード：D0804-09073 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、134ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、非侵襲性ドラッグデリバリーの世界市場を広く調査・分析し、今後の市場展望をまとめております。非侵襲性ドラッグデリバリーの種類別市場規模（人工膵臓、無針注射器、デジタル呼吸器、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Adherium Limited、Novartis AG、Diabeloop SA、Capsule Technologies, Inc.、Medtronic Plc.、Crossject S.A.、PharmaJet、Inovio Pharmaceuticals, Inc.、HNS International, Inc.、PenJet Corporation、Teva Pharmaceuticals Industries Ltd.、Portal Instruments、Tandem Diabetes Care, Inc.、ResMed、Sensiron AG ・地域別グローバル市場分析 2015年-2020年 ・非侵襲性ドラッグデリバリーの北米市場（アメリカ、カナダ、メキシコ） ・非侵襲性ドラッグデリバリーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・非侵襲性ドラッグデリバリーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・非侵襲性ドラッグデリバリーの南米市場（ブラジル、アルゼンチン） ・非侵襲性ドラッグデリバリーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：人工膵臓、無針注射器、デジタル呼吸器、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Non-Invasive Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Non-Invasive Drug Delivery sales will be xx in 2020 from Non-Invasive Drug Delivery million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Non-Invasive Drug Delivery market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Non-Invasive Drug Delivery industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Non-Invasive Drug Delivery and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Non-Invasive Drug Delivery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Non-Invasive Drug Delivery market has been segmented into
Artificial Pancreas
Needle Free Injector
Digital Respiratory Devices
Other
By Application, Non-Invasive Drug Delivery has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-Invasive Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-Invasive Drug Delivery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-Invasive Drug Delivery market.
The report offers in-depth assessment of the growth and other aspects of the Non-Invasive Drug Delivery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Non-Invasive Drug Delivery Market Share Analysis
Non-Invasive Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non-Invasive Drug Delivery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-Invasive Drug Delivery sales, revenue and market share for each player covered in this report.
The major players covered in Non-Invasive Drug Delivery are:
Adherium Limited
Novartis AG
Diabeloop SA
Capsule Technologies, Inc.
Medtronic Plc.
Crossject S.A.
PharmaJet
Inovio Pharmaceuticals, Inc.
HNS International, Inc.
PenJet Corporation
Teva Pharmaceuticals Industries Ltd.
Portal Instruments
Tandem Diabetes Care, Inc.
ResMed
Sensiron AG
Among other players domestic and global, Non-Invasive Drug Delivery market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Invasive Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-Invasive Drug Delivery, with price, sales, revenue and global market share of Non-Invasive Drug Delivery in 2018 and 2019.
Chapter 3, the Non-Invasive Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Invasive Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Non-Invasive Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Non-Invasive Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Non-Invasive Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-Invasive Drug Delivery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Artificial Pancreas
1.2.3 Needle Free Injector
1.2.4 Digital Respiratory Devices
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-Invasive Drug Delivery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global Non-Invasive Drug Delivery Market
1.4.1 Global Non-Invasive Drug Delivery Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Non-Invasive Drug Delivery Industry Impact
1.6.1 COVID-19 Potential Implications for the Non-Invasive Drug Delivery
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Non-Invasive Drug Delivery
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Adherium Limited
2.1.1 Adherium Limited Details
2.1.2 Adherium Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Adherium Limited SWOT Analysis
2.1.4 Adherium Limited Product and Services
2.1.5 Adherium Limited Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis AG SWOT Analysis
2.2.4 Novartis AG Product and Services
2.2.5 Novartis AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Diabeloop SA
2.3.1 Diabeloop SA Details
2.3.2 Diabeloop SA Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Diabeloop SA SWOT Analysis
2.3.4 Diabeloop SA Product and Services
2.3.5 Diabeloop SA Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Capsule Technologies, Inc.
2.4.1 Capsule Technologies, Inc. Details
2.4.2 Capsule Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Capsule Technologies, Inc. SWOT Analysis
2.4.4 Capsule Technologies, Inc. Product and Services
2.4.5 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Medtronic Plc.
2.5.1 Medtronic Plc. Details
2.5.2 Medtronic Plc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Medtronic Plc. SWOT Analysis
2.5.4 Medtronic Plc. Product and Services
2.5.5 Medtronic Plc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Crossject S.A.
2.6.1 Crossject S.A. Details
2.6.2 Crossject S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Crossject S.A. Product and Services
2.6.4 Crossject S.A. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 PharmaJet
2.7.1 PharmaJet Details
2.7.2 PharmaJet Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 PharmaJet Product and Services
2.7.4 PharmaJet Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Inovio Pharmaceuticals, Inc.
2.8.1 Inovio Pharmaceuticals, Inc. Details
2.8.2 Inovio Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Inovio Pharmaceuticals, Inc. Product and Services
2.8.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 HNS International, Inc.
2.9.1 HNS International, Inc. Details
2.9.2 HNS International, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 HNS International, Inc. Product and Services
2.9.4 HNS International, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 PenJet Corporation
2.10.1 PenJet Corporation Details
2.10.2 PenJet Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 PenJet Corporation Product and Services
2.10.4 PenJet Corporation Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceuticals Industries Ltd.
2.11.1 Teva Pharmaceuticals Industries Ltd. Details
2.11.2 Teva Pharmaceuticals Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceuticals Industries Ltd. Product and Services
2.11.4 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Portal Instruments
2.12.1 Portal Instruments Details
2.12.2 Portal Instruments Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Portal Instruments Product and Services
2.12.4 Portal Instruments Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Tandem Diabetes Care, Inc.
2.13.1 Tandem Diabetes Care, Inc. Details
2.13.2 Tandem Diabetes Care, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Tandem Diabetes Care, Inc. Product and Services
2.13.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 ResMed
2.14.1 ResMed Details
2.14.2 ResMed Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ResMed Product and Services
2.14.4 ResMed Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sensiron AG
2.15.1 Sensiron AG Details
2.15.2 Sensiron AG Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Sensiron AG Product and Services
2.15.4 Sensiron AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Non-Invasive Drug Delivery Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Non-Invasive Drug Delivery Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Non-Invasive Drug Delivery Manufacturer Market Share in 2019
3.3.2 Top 6 Non-Invasive Drug Delivery Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Non-Invasive Drug Delivery Sales, Revenue and Market Share by Regions
4.1.1 Global Non-Invasive Drug Delivery Sales and Market Share by Regions (2015-2020)
4.1.2 Global Non-Invasive Drug Delivery Revenue and Market Share by Regions (2015-2020)
4.2 North America Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
4.3 Europe Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
4.5 South America Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Non-Invasive Drug Delivery Sales, Revenue and Market Share by Country
5.1.1 North America Non-Invasive Drug Delivery Sales and Market Share by Country (2015-2020)
5.1.2 North America Non-Invasive Drug Delivery Revenue and Market Share by Country (2015-2020)
5.2 United States Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
5.3 Canada Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
5.4 Mexico Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Non-Invasive Drug Delivery Sales, Revenue and Market Share by Country
6.1.1 Europe Non-Invasive Drug Delivery Sales and Market Share by Country (2015-2020)
6.1.2 Europe Non-Invasive Drug Delivery Revenue and Market Share by Country (2015-2020)
6.2 Germany Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
6.3 UK Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
6.4 France Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
6.5 Russia Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
6.6 Italy Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Non-Invasive Drug Delivery Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Non-Invasive Drug Delivery Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Non-Invasive Drug Delivery Revenue and Market Share by Regions (2015-2020)
7.2 China Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
7.3 Japan Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
7.4 Korea Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
7.5 India Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
7.7 Australia Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Non-Invasive Drug Delivery Sales, Revenue and Market Share by Country
8.1.1 South America Non-Invasive Drug Delivery Sales and Market Share by Country (2015-2020)
8.1.2 South America Non-Invasive Drug Delivery Revenue and Market Share by Country (2015-2020)
8.2 Brazil Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
8.3 Argentina Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Non-Invasive Drug Delivery Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Non-Invasive Drug Delivery Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Non-Invasive Drug Delivery Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
9.3 Turkey Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
9.4 Egypt Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
9.5 South Africa Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Non-Invasive Drug Delivery Sales and Market Share by Type (2015-2020)
10.2 Global Non-Invasive Drug Delivery Revenue and Market Share by Type (2015-2020)
10.3 Global Non-Invasive Drug Delivery Price by Type (2015-2020)
11 Global Non-Invasive Drug Delivery Market Segment by Application
11.1 Global Non-Invasive Drug Delivery Sales Market Share by Application (2015-2020)
11.2 Global Non-Invasive Drug Delivery Revenue Market Share by Application (2015-2020)
11.3 Global Non-Invasive Drug Delivery Price by Application (2015-2020)
12 Market Forecast
12.1 Global Non-Invasive Drug Delivery Sales, Revenue and Growth Rate (2021-2025)
12.2 Non-Invasive Drug Delivery Market Forecast by Regions (2021-2025)
12.2.1 North America Non-Invasive Drug Delivery Market Forecast (2021-2025)
12.2.2 Europe Non-Invasive Drug Delivery Market Forecast (2021-2025)
12.2.3 Asia-Pacific Non-Invasive Drug Delivery Market Forecast (2021-2025)
12.2.4 South America Non-Invasive Drug Delivery Market Forecast (2021-2025)
12.2.5 Middle East & Africa Non-Invasive Drug Delivery Market Forecast (2021-2025)
12.3 Non-Invasive Drug Delivery Market Forecast by Type (2021-2025)
12.3.1 Global Non-Invasive Drug Delivery Sales Forecast by Type (2021-2025)
12.3.2 Global Non-Invasive Drug Delivery Market Share Forecast by Type (2021-2025)
12.4 Non-Invasive Drug Delivery Market Forecast by Application (2021-2025)
12.4.1 Global Non-Invasive Drug Delivery Sales Forecast by Application (2021-2025)
12.4.2 Global Non-Invasive Drug Delivery Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Non-Invasive Drug Delivery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non-Invasive Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-Invasive Drug Delivery Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Non-Invasive Drug Delivery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Adherium Limited Basic Information, Manufacturing Base and Competitors
Table 9. Adherium Limited Non-Invasive Drug Delivery Major Business
Table 10. Adherium Limited Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 11. Adherium Limited SWOT Analysis
Table 12. Adherium Limited Non-Invasive Drug Delivery Product and Services
Table 13. Adherium Limited Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 15. Novartis AG Non-Invasive Drug Delivery Major Business
Table 16. Novartis AG Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 17. Novartis AG SWOT Analysis
Table 18. Novartis AG Non-Invasive Drug Delivery Product and Services
Table 19. Novartis AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Diabeloop SA Basic Information, Manufacturing Base and Competitors
Table 21. Diabeloop SA Non-Invasive Drug Delivery Major Business
Table 22. Diabeloop SA Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 23. Diabeloop SA SWOT Analysis
Table 24. Diabeloop SA Non-Invasive Drug Delivery Product and Services
Table 25. Diabeloop SA Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Capsule Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 27. Capsule Technologies, Inc. Non-Invasive Drug Delivery Major Business
Table 28. Capsule Technologies, Inc. Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 29. Capsule Technologies, Inc. SWOT Analysis
Table 30. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product and Services
Table 31. Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Medtronic Plc. Basic Information, Manufacturing Base and Competitors
Table 33. Medtronic Plc. Non-Invasive Drug Delivery Major Business
Table 34. Medtronic Plc. Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 35. Medtronic Plc. SWOT Analysis
Table 36. Medtronic Plc. Non-Invasive Drug Delivery Product and Services
Table 37. Medtronic Plc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Crossject S.A. Basic Information, Manufacturing Base and Competitors
Table 39. Crossject S.A. Non-Invasive Drug Delivery Major Business
Table 40. Crossject S.A. Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 41. Crossject S.A. SWOT Analysis
Table 42. Crossject S.A. Non-Invasive Drug Delivery Product and Services
Table 43. Crossject S.A. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. PharmaJet Basic Information, Manufacturing Base and Competitors
Table 45. PharmaJet Non-Invasive Drug Delivery Major Business
Table 46. PharmaJet Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 47. PharmaJet SWOT Analysis
Table 48. PharmaJet Non-Invasive Drug Delivery Product and Services
Table 49. PharmaJet Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Inovio Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 51. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Major Business
Table 52. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 53. Inovio Pharmaceuticals, Inc. SWOT Analysis
Table 54. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product and Services
Table 55. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. HNS International, Inc. Basic Information, Manufacturing Base and Competitors
Table 57. HNS International, Inc. Non-Invasive Drug Delivery Major Business
Table 58. HNS International, Inc. Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 59. HNS International, Inc. SWOT Analysis
Table 60. HNS International, Inc. Non-Invasive Drug Delivery Product and Services
Table 61. HNS International, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. PenJet Corporation Basic Information, Manufacturing Base and Competitors
Table 63. PenJet Corporation Non-Invasive Drug Delivery Major Business
Table 64. PenJet Corporation Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 65. PenJet Corporation SWOT Analysis
Table 66. PenJet Corporation Non-Invasive Drug Delivery Product and Services
Table 67. PenJet Corporation Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Major Business
Table 70. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 71. Teva Pharmaceuticals Industries Ltd. SWOT Analysis
Table 72. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product and Services
Table 73. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Portal Instruments Basic Information, Manufacturing Base and Competitors
Table 75. Portal Instruments Non-Invasive Drug Delivery Major Business
Table 76. Portal Instruments Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 77. Portal Instruments SWOT Analysis
Table 78. Portal Instruments Non-Invasive Drug Delivery Product and Services
Table 79. Portal Instruments Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Tandem Diabetes Care, Inc. Basic Information, Manufacturing Base and Competitors
Table 81. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Major Business
Table 82. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 83. Tandem Diabetes Care, Inc. SWOT Analysis
Table 84. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product and Services
Table 85. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. ResMed Basic Information, Manufacturing Base and Competitors
Table 87. ResMed Non-Invasive Drug Delivery Major Business
Table 88. ResMed Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 89. ResMed SWOT Analysis
Table 90. ResMed Non-Invasive Drug Delivery Product and Services
Table 91. ResMed Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Sensiron AG Basic Information, Manufacturing Base and Competitors
Table 93. Sensiron AG Non-Invasive Drug Delivery Major Business
Table 94. Sensiron AG Non-Invasive Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 95. Sensiron AG SWOT Analysis
Table 96. Sensiron AG Non-Invasive Drug Delivery Product and Services
Table 97. Sensiron AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Global Non-Invasive Drug Delivery Sales by Manufacturer (2018-2019) (K Units)
Table 99. Global Non-Invasive Drug Delivery Revenue by Manufacturer (2018-2019) (USD Million)
Table 100. Global Non-Invasive Drug Delivery Sales by Regions (2015-2020) (K Units)
Table 101. Global Non-Invasive Drug Delivery Sales Market Share by Regions (2015-2020)
Table 102. Global Non-Invasive Drug Delivery Revenue by Regions (2015-2020) (USD Million)
Table 103. North America Non-Invasive Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 104. North America Non-Invasive Drug Delivery Sales Market Share by Countries (2015-2020)
Table 105. North America Non-Invasive Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 106. North America Non-Invasive Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 107. Europe Non-Invasive Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 108. Europe Non-Invasive Drug Delivery Sales Market Share by Countries (2015-2020)
Table 109. Europe Non-Invasive Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 110. Asia-Pacific Non-Invasive Drug Delivery Sales by Regions (2015-2020) (K Units)
Table 111. Asia-Pacific Non-Invasive Drug Delivery Sales Market Share by Regions (2015-2020)
Table 112. Asia-Pacific Non-Invasive Drug Delivery Revenue by Regions (2015-2020) (USD Million)
Table 113. South America Non-Invasive Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 114. South America Non-Invasive Drug Delivery Sales Market Share by Countries (2015-2020)
Table 115. South America Non-Invasive Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 116. South America Non-Invasive Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 117. Middle East & Africa Non-Invasive Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 118. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Countries (2015-2020)
Table 119. Middle East & Africa Non-Invasive Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 120. Middle East & Africa Non-Invasive Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 121. Global Non-Invasive Drug Delivery Sales by Type (2015-2020) (K Units)
Table 122. Global Non-Invasive Drug Delivery Sales Share by Type (2015-2020)
Table 123. Global Non-Invasive Drug Delivery Revenue by Type (2015-2020) (USD Million)
Table 124. Global Non-Invasive Drug Delivery Revenue Share by Type (2015-2020)
Table 125. Global Non-Invasive Drug Delivery Sales by Application (2015-2020) (K Units)
Table 126. Global Non-Invasive Drug Delivery Sales Share by Application (2015-2020)
Table 127. Global Non-Invasive Drug Delivery Sales Forecast by Regions (2021-2025) (K Units)
Table 128. Global Non-Invasive Drug Delivery Market Share Forecast by Regions (2021-2025)
Table 129. Global Non-Invasive Drug Delivery Sales Forecast by Type (2021-2025) (K Units)
Table 130. Global Non-Invasive Drug Delivery Market Share Forecast by Type (2021-2025)
Table 131. Global Non-Invasive Drug Delivery Sales Forecast by Application (2021-2025)
Table 132. Global Non-Invasive Drug Delivery Market Share Forecast by Application (2021-2025)
Table 133. Direct Channel Pros & Cons
Table 134. Indirect Channel Pros & Cons
Table 135. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Non-Invasive Drug Delivery Picture
Figure 2. Global Sales Market Share of Non-Invasive Drug Delivery by Type in 2019
Figure 3. Artificial Pancreas Picture
Figure 4. Needle Free Injector Picture
Figure 5. Digital Respiratory Devices Picture
Figure 6. Other Picture
Figure 7. Non-Invasive Drug Delivery Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Non-Invasive Drug Delivery Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Non-Invasive Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Non-Invasive Drug Delivery Sales Market Share by Manufacturer in 2019
Figure 32. Global Non-Invasive Drug Delivery Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Non-Invasive Drug Delivery Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Non-Invasive Drug Delivery Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Non-Invasive Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Non-Invasive Drug Delivery Revenue Market Share by Regions (2015-2020)
Figure 39. Global Non-Invasive Drug Delivery Revenue Market Share by Regions in 2018
Figure 40. North America Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
Figure 41. Europe Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
Figure 43. South America Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020)
Figure 45. North America Non-Invasive Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Non-Invasive Drug Delivery Sales Market Share by Countries (2015-2020)
Figure 47. North America Non-Invasive Drug Delivery Sales Market Share by Countries in 2018
Figure 48. North America Non-Invasive Drug Delivery Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Non-Invasive Drug Delivery Revenue Market Share by Countries in 2018
Figure 50. United States Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Non-Invasive Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Non-Invasive Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Non-Invasive Drug Delivery Revenue Market Share by Countries in 2019
Figure 56. Germany Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Non-Invasive Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Non-Invasive Drug Delivery Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Non-Invasive Drug Delivery Revenue Market Share by Regions 2019
Figure 64. China Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Non-Invasive Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Non-Invasive Drug Delivery Sales Market Share by Countries in 2019
Figure 71. South America Non-Invasive Drug Delivery Revenue Market Share by Countries in 2019
Figure 72. Brazil Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Non-Invasive Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Non-Invasive Drug Delivery Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Non-Invasive Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Non-Invasive Drug Delivery Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Non-Invasive Drug Delivery Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Non-Invasive Drug Delivery Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Non-Invasive Drug Delivery Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Non-Invasive Drug Delivery Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Non-Invasive Drug Delivery Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Non-Invasive Drug Delivery Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Non-Invasive Drug Delivery Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Non-Invasive Drug Delivery Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
経鼻ドラッグデリバリーデバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nasal Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nasal Drug Delive…- 結腸標的薬物送達の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Colon Targeting Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 結腸標的薬物送達の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Colon Targeting Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 眼薬物送達システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ocular Drug Delivery System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ocular Drug Deliv…
- スマートピルドラッグデリバリーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Smart Pills Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Smart Pills Drug De…